CX3CR1 and neoplasm: The authors extended this finding with single-cell RNA and T-cell receptor (TCR) sequencing in longitudinally obtained blood samples as compared with tumor tissue and demonstrated changes in transcriptomic signatures of T cells as well as evolution of TCR clonotypes in peripheral blood containing highly frequent TIL repertoires that overexpress CX3CR1.